There were a couple of great articles in JAMA Internal Medicine this week on cancer drug development and pricing.
The first, discussed in this NYTimes article, did a thorough job of tallying the total R&D cost to bring a new cancer drug to market. The study authors ended up with a significantly lower number than has been reported in the past.
“Following approval, the 10 drugs together brought in $67 billion, the researchers also concluded — a more than sevenfold return on investment. Nine out of 10 companies made money, but revenues varied enormously. One drug had not yet earned back its development costs.”
Continue reading Health Policy Updates: September 16 2017
What would it take to make the US health care system the best in the world? We already spend more money (by far) on health care than any other country, but our results are middling (see the figure below). Recent thoughts on what the US might do in order to translate our huge financial investment in health into better results, in the NEJM.
“The first challenge the U.S. health care system must confront is lack of access to health care…Affordable and comprehensive insurance coverage is fundamental. If people are uninsured, some delay seeking care, some of those end up with serious health problems, and some of them die.
The second challenge is the relative underinvestment in primary care in the United States as compared with other countries…In contrast to the United States, a higher percentage of these countries’ professional workforce is dedicated to primary care than to specialty care, and they enable delivery of a wider range of services at first contact…” Continue reading Health Policy Updates: August 19 2017
If the US healthcare system isn’t going to provide clear and transparent prices to patients, then others are trying to provide that information on their own. Several companies are trying to inform consumers to the lowest-cost sources for generic drugs.
“One company, GoodRx, collects drug prices at pharmacies around the country and connects consumers to coupons to help them pay. Another, Blink Health, takes the process a step further by allowing customers to pay for their drugs online, then pick up the prescription at nearly any pharmacy.” Continue reading Health Policy Updates: February 20 2016
More on the Bernie Sanders health care plan – and it’s financial costs. As the usually left-leaning Vox.com points out, a single-payer plan such as Sanders proposes would required tax increases far larger than what Americans have been able to stomach.
“Vermont’s failed single-payer attempt helps explain the difficulties a Sanders administration would face in building a Medicare-for-all system. Like Vermont, the United States would also need a massive tax increase to build a health care system like Canada’s.”
Continue reading Health Policy Updates: January 30 2016
Bernie Sander’s new single-payer health care plan was introduced at the beginning of the week, and Ezra KIein of the left-leaning Vox media was not so keen. Big promises of new benefits, but where exactly was the money to pay for it coming from?
“All in all, Sanders wants to raise taxes by a bit over a trillion dollars per year — which may not sound like much to those who remember the Obamacare debate, but remember that the numbers that got thrown around for Obamacare were 10-year estimates. Adding inflation, Sanders will be raising taxes by close to $15 trillion when the Congressional Budget Office applies its normal scoring window.”
Continue reading Health Policy Updates: January 22 2016